A nurse is preparing to administer levothyroxine 0.175 mg PO once a day. The amount available is levothyroxine 88 mcg/tablet. How many tablets should the nurse administer per dose? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero)
The Correct Answer is ["2"]
To calculate the number of tablets to administer, you need to convert the dose to micrograms (mcg) to match the tablet strength:
0.175 mg is equivalent to 175 mcg (since 1 mg = 1000 mcg).
Now, divide the required dose (175 mcg) by the strength of the available tablets (88 mcg/tablet):
175 mcg ÷ 88 mcg/tablet ≈ 1.9886
Rounding to the nearest whole number, you should administer 2 tablets per dose.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A.Growth of that leg may be affected.
When a fracture occurs near the epiphyseal plate of a long bone, such as the femur, there is a risk of damage to the growth plate. The growth plate (epiphyseal plate) is responsible for longitudinal bone growth in children. If the growth plate is injured or damaged during the fracture, it can potentially lead to growth disturbances and affect the growth of that leg.
B. Risk for infection at this location is increased: While any fracture has a risk of infection, the proximity to the epiphyseal plate doesn't necessarily increase the risk of infection.
C. Long bones contain marrow, which increases the risk for anemia: The presence of bone marrow in long bones is unrelated to the potential effects on bone growth after a fracture near the epiphyseal plate.
D. Fracture repair will necessitate prolonged traction: The use of traction for fracture repair can vary depending on the type and location of the fracture. However, the primary concern with a fracture near the epiphyseal plate is its potential impact on bone growth.
Correct Answer is D
Explanation
Option A, "Fatigue," is a symptom of anemia but is not a long-term complication associated with Thalassemia major.
Option B, "Deferoxamine usage," is a treatment to manage iron overload and not a complication associated with Thalassemia major.
Option C, "Immunosuppressive therapy," is not typically used to manage Thalassemia major and is not a long-term complication but rather a potential treatment for certain cases of thalassemia.
Option D. Hemochromatosis/Hemosiderosis
Thalassemia major is a genetic disorder that results in the body's inability to produce enough hemoglobin, leading to severe anemia.
To manage this condition, frequent blood transfusions are required, which can lead to iron overload in the body. Excess iron gets deposited in various organs and tissues, causing damage.
Hemochromatosis or hemosiderosis is a condition characterized by the accumulation of iron in organs like the liver, heart, and endocrine glands, which can result from repeated blood transfusions.
The complications associated with iron overload include liver damage, heart problems, diabetes, and more. Treatment with iron chelating agents like deferoxamine is often necessary to remove excess iron from the body.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.